(Q73800856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Normal polyclonal immunoglobulins ('IVIg') inhibit microglial phagocytosis in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

M Stangel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

N J Scolding

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D A Compston

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 July 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

137-144

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

Intravenous immunoglobulin treatment of experimental T cell-mediated autoimmune disease. Upregulation of T cell proliferation and downregulation of tumor necrosis factor alpha secretion

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Intravenous immunoglobulin treatment in multiple sclerosis. Effect on relapses.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Mechanisms of phagocytosis in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Molecular definition of distinct cytoskeletal structures involved in complement- and Fc receptor-mediated phagocytosis in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Phagocytozing ameboid microglial cells studied in a mouse corpus callosum slice preparation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Activation of macrophages by recombinant interferon-gamma has no effect on myelin phagocytosis but hinders invasion of nerves in organ culture

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

A role for complement in phagocytosis of myelin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Manipulating the Immune System with Immune Globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Randomised placebo-controlled trial of monthly intravenous immunoglobulin therapy in relapsing-remitting multiple sclerosis. Austrian Immunoglobulin in Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Identification of autoantibodies associated with myelin damage in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Characterization of ameboid microglia isolated from developing mammalian brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Microglia as mediators of inflammatory and degenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

beta-Interferon regulates the immunomodulatory activity of neonatal rodent microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

A rapid and sensitive method allowing photometric determination of erythrophagocytosis by mononuclear phagocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Effect of polymeric IgG on human monocyte functions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Do Antibodies Stimulate Myelin Repair in Multiple Sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

A shift in encephalitogenic T cell cytokine pattern is associated with suppression of EAE by intravenous immunoglobulins (IVIg)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

High avidity IFN-neutralizing antibodies in pharmaceutically prepared human IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Effectiveness of four intravenous IgG preparations in prevention of phagocytosis of anti-Rh-(D)-coated erythrocytes by mononuclear phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Macrophage and microglial responses to cytokines in vitro: phagocytic activity, proteolytic enzyme release, and free radical production

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Indictment of the microglia as the villain in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Phagocytosis: flow cytometric quantitation with fluorescent microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Microglial phagocytosis is modulated by pro- and anti-inflammatory cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

Molecular mechanisms of microglial activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900210-1

7 January 2021

10.1016/S0165-5728(00)00210-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10814791%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference